
PMC:7536913 / 1441-3053
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T2 | 1004-1009 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T3 | 1068-1072 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
T4 | 1092-1099 | Body_part | denotes | trachea | http://purl.org/sig/ont/fma/fma7394 |
T5 | 1104-1112 | Body_part | denotes | bronchus | http://purl.org/sig/ont/fma/fma7409 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 1004-1009 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T2 | 1068-1072 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
T3 | 1092-1099 | Body_part | denotes | trachea | http://purl.obolibrary.org/obo/UBERON_0003126 |
T4 | 1104-1112 | Body_part | denotes | bronchus | http://purl.obolibrary.org/obo/UBERON_0002185 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T8 | 581-589 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T9 | 995-1017 | Disease | denotes | ischemic heart disease | http://purl.obolibrary.org/obo/MONDO_0024644 |
T10 | 1004-1017 | Disease | denotes | heart disease | http://purl.obolibrary.org/obo/MONDO_0005267 |
T11 | 1022-1028 | Disease | denotes | stroke | http://purl.obolibrary.org/obo/MONDO_0005098|http://purl.obolibrary.org/obo/MONDO_0011057 |
T13 | 1068-1080 | Disease | denotes | lung cancers | http://purl.obolibrary.org/obo/MONDO_0008903 |
T14 | 1104-1120 | Disease | denotes | bronchus cancers | http://purl.obolibrary.org/obo/MONDO_0001672 |
T15 | 1238-1246 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T16 | 1396-1404 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 369-370 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T9 | 709-721 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | Organization |
T10 | 1004-1009 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T11 | 1004-1009 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T12 | 1004-1009 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T13 | 1004-1009 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T14 | 1068-1072 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T15 | 1068-1072 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
T16 | 1104-1112 | http://purl.obolibrary.org/obo/UBERON_0002185 | denotes | bronchus |
T17 | 1176-1179 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T18 | 1547-1554 | http://www.ebi.ac.uk/efo/EFO_0000881 | denotes | digital |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T4 | 455-460 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
28 | 581-589 | Disease | denotes | COVID‐19 | MESH:C000657245 |
29 | 787-795 | Disease | denotes | Covid‐19 | MESH:C000657245 |
30 | 806-812 | Disease | denotes | deaths | MESH:D003643 |
31 | 913-918 | Disease | denotes | death | MESH:D003643 |
32 | 975-981 | Disease | denotes | deaths | MESH:D003643 |
33 | 995-1017 | Disease | denotes | ischemic heart disease | MESH:D003324 |
34 | 1022-1028 | Disease | denotes | stroke | MESH:D020521 |
35 | 1068-1080 | Disease | denotes | lung cancers | MESH:D008175 |
36 | 1092-1120 | Disease | denotes | trachea and bronchus cancers | MESH:D009369 |
37 | 1148-1154 | Disease | denotes | deaths | MESH:D003643 |
38 | 1238-1246 | Disease | denotes | COVID‐19 | MESH:C000657245 |
39 | 1396-1404 | Disease | denotes | COVID‐19 | MESH:C000657245 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 1022-1028 | Phenotype | denotes | stroke | http://purl.obolibrary.org/obo/HP_0001297 |
T2 | 1068-1080 | Phenotype | denotes | lung cancers | http://purl.obolibrary.org/obo/HP_0100526 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T12 | 0-184 | Sentence | denotes | Some of the new policies and procedures allowed regulators to completely reprioritize existing high‐priority public health work and reallocate internal resources in unprecedented ways. |
T13 | 185-304 | Sentence | denotes | Arguably, such changes should be reserved for public health emergencies because they are unsustainable in the long run. |
T14 | 305-691 | Sentence | denotes | However, other interim policies have the potential to endure in a “new normal” way of working to better address public health needs (e.g., repurposed drugs and their combinations with novel therapies), while specific risk‐based policies to accelerate development of potential COVID‐19 therapies and vaccines to an unprecedented level might be applied to other life‐threatening diseases. |
T15 | 692-838 | Sentence | denotes | The World Health Organization (WHO) reports, as of August 10, 2020, the total number of global Covid‐19 confirmed deaths is approximately 728,000. |
T16 | 839-919 | Sentence | denotes | 3 For perspective, this figure is lower than for other leading causes of death. |
T17 | 920-1155 | Sentence | denotes | For example, WHO reported the leading causes of global deaths in 2016 were ischemic heart disease and stroke, which claimed 15.2 million lives, and lung cancers (including trachea and bronchus cancers), which caused 1.7 million deaths. |
T18 | 1156-1285 | Sentence | denotes | 4 And as the world has witnessed the economic and societal costs associated with COVID‐19, other diseases share similar burdens. |
T19 | 1286-1405 | Sentence | denotes | These data indicate it would be appropriate to apply the same sense of urgency and innovation to areas beyond COVID‐19. |
T20 | 1406-1610 | Sentence | denotes | We are supportive of many of the proposals being discussed by regulators and other groups identifying transformative practices, e.g., use of digital technologies and flexibility in statistical approaches. |
T21 | 1611-1612 | Sentence | denotes | 5 |